论文部分内容阅读
五加科植物三七Panax notoginseng(Burk.)F.H.Chen,主产于云南,入药主要为其干燥根,使用历史悠久,畅销全国各地,并有大量出口。近年,已被临床用于冠心病、弥漫性血管内凝血等急症的治疗。但因药材抗凝活性之强弱,对治疗效果关系很大,临床上又难于控制内在质量。因此,考察不同产地、不同等级规格、不同季节采挖之三七,对凝血作用影响,以制定质量标准和合理的检测方法、临床科学用药是十分必要的。为此,我们对三七作了一些体外实验研究。
Araliaceae plant Panax notoginseng (Burk.) F.H. Chen, mainly produced in Yunnan, mainly for its dry roots, a long history of use, best-selling throughout the country, and a large number of exports. In recent years, it has been used clinically for the treatment of acute diseases such as coronary heart disease and diffuse intravascular coagulation. However, due to the strong anti-coagulant activity of medicinal herbs, the therapeutic effect is very important, and it is difficult to control the internal quality in clinical practice. Therefore, it is necessary to examine the effects of coagulation on different production areas, different grade specifications, and different seasons of extraction and digging, in order to establish quality standards, reasonable detection methods, and clinical scientific drugs. To this end, we made some in vitro experiments on Panax notoginseng.